References
- Song, X. F.; Fan, J.; Liu, L.; Liu, X. F.; Gao, F. Coumarin Derivatives with Anticancer Activities: An Update. Arch. Pharm. 2020, 353, 2000025. DOI: https://doi.org/10.1002/ardp.202000025.
- Thomas, V.; Giles, D.; Basavarajaswamy, G.; Das, A.; Patel, A. Coumarin Derivatives as anti-Inflammatory and Anticancer Agents. Anticancer Agents Med Chem. 2017, 17, 415–423. DOI: https://doi.org/10.2174/1871520616666160902094739.
- Duangdee, N.; Mahavorasirikul, W.; Prateeptongkum, S. Design Synthesis and anti-Proliferative Activity of Some New Coumarin Substituted Hydrazide–Hydrazine Derivatives. J. Chem. Sci. 2020, 132, DOI: https://doi.org/10.1007/s12039-020-01767-4.
- Majnooni, M. B.; Fakhri, S.; Smeriglio, A.; Trombetta, D.; Croley, C. R.; Bhattacharyya, P.; Sobarzo-Sánchez, E.; Farzaei, M. H.; Bishayee, A. Antiangiogenic Effects of Coumarins against Cancer: From Chemistry to Medicine. Molecules 2019, 24, 4278. DOI: https://doi.org/10.3390/molecules24234278.
- Govori, S.; Kaljaj, V.; Rapic, V.; Kaljaj, L.; Đakovic, S. Synthesis and Structure of Some 3,4-Annelated Coumarin Systems. Heterocyc. Commun. 2002, 8, 129–134. DOI: https://doi.org/10.1515/HC.2002.8.2.129.
- Govori, S.; Spahiu, S.; Haziri, A. In Vitro Microbiological Evaluation of Novel 2-oxo2H-Chromene-3-Carbaldehyde Containing 1,3,4-Thiadiazole Moiety. Toxicol. Environ. Chem. 2014, 96, 1366–1373. DOI: https://doi.org/10.1080/02772248.2015.1023034.
- Ganot, N.; Redko, B.; Gellerman, G.; Tshuva, E. Y. Anti-Proliferative Activity of the Combination of Salan Ti(iv) Complexes with Other Organic and Inorganic Anticancer Drugs against HT-29 and NCI-H1229 Cells: Synergism with Cisplatin. RSC Adv. 2015, 5, 7874–7879. DOI: https://doi.org/10.1039/C4RA13484B.
- Tshuva, E. Y.; Miller, M. Coordination Complexes of Titanium(IV) for Anticancer Therapy. Metallo-Drugs: Development and Action of Anticancer Agents 2018, 219–250. DOI: https://doi.org/10.1515/9783110470734-008.
- Kumar, N.; Kaushal, R.; Chaudhary, A.; Arora, S.; Awasthi, P. Synthesis, Structural Elucidation, and in Vitro Antiproliferative Activities of Mixed-Ligand Titanium Complexes. Med. Chem. Res. 2014, 23, 3897–3906. DOI: https://doi.org/10.1007/s00044-014-0963-7.
- Alkış, M. E.; Buldurun, K.; Turan, N.; Alan, Y.; Yılmaz, Ü. K.; Mantarcı, A. Synthesis, Characterization, Antiproliferative of Pyrimidine Based Ligand and Its Ni(II) and Pd(II) Complexes and Effectiveness of Electroporation. J. Biomol. Struct. Dyn. 2020, 1, 1–11. DOI: https://doi.org/10.1080/07391102.2020.1852965.
- Caglar, S.; Altay, A.; Kuzucu, M.; Caglar, B. In Vitro Anticancer Activity of Novel Co(II) and Ni(II) Complexes of Non-Steroidal anti-Inflammatory Drug Niflumic Acid against Human Breast Adenocarcinoma MCF-7 Cells. Cell Biochem. Biophys. 2021, 79, 729–746. DOI: https://doi.org/10.1007/s12013-021-00984-z.
- Pahonțu, E.; Ilieș, D.-C.; Shova, S.; Oprean, C.; Păunescu, V.; Olaru, O.; Rădulescu, F.; Gulea, A.; Roșu, T.; Drăgănescu, D. Synthesis, Characterization, Antimicrobial and Antiproliferative Activity Evaluation of Cu(II), Co(II), Zn(II), Ni(II) and Pt(II) Complexes with Isoniazid-Derived Compound. Molecules 2017, 22, 650. DOI: https://doi.org/10.3390/molecules22040650.
- Mossman, T. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays. J. Immunol. Methods 1983, 65, 55–63. DOI: https://doi.org/10.1016/0022-1759(83)90303-4.
- Boyd, M. R.; Kenneth, D. P. Some Practical Considerations and Applications of the National Cancer Institute in Vitro Anticancer Drug Discovery Screen. Drug Dev. Res. 1995, 34, 91–109. DOI: https://doi.org/10.1002/ddr.430340203.
- www.dtp.nci.nih.gov.
- Bindoli, A.; Pia, M.; Scutari, G.; Gabbiani, C.; Casini, A.; Messori, L. Thioredoxin Reductase: A Target for Gold Compounds Acting as Potential Anticancer Drugs. Coord. Chem. Rev. 2009, 253, 1692–1707. DOI: https://doi.org/10.1016/j.ccr.2009.02.026.
- Kostova, I. Ruthenium Complexes as Anticancer Agents. Curr. Med. Chem. 2006, 13, 1085–1107. DOI: https://doi.org/10.2174/092986706776360941.